S'abonner

Profiles of differential expression of miRNAs in the late stage of red blood cell preservation and their potential roles - 30/10/24

Doi : 10.1016/j.tracli.2024.09.003 
Yajie Wang a, 1, Yiming Ma a, 1, Liping Sun b, Quan Rao c, Xiaozhou Yuan a, Yan Chen a, Xiaofei Li a,
a Department of Blood Transfusion, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China 
b Department of Transfusion Medicine, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China 
c Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China 

Corresponding author at: Department of Blood Transfusion, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong-an Road, Xi-Cheng District, Beijing 100050, China.Department of Blood TransfusionBeijing Friendship HospitalCapital Medical UniversityNo. 95 Yong-an Road, Xi-Cheng DistrictBeijing100050China

Highlights

We screened the expression profiles of miRNAs in the late stage of RBC preservation.
We identified miRNAs that changed during different storage times as well as potential target genes.
We predicted the potential regulatory effects of these differential miRNAs through bioinformatics.

Le texte complet de cet article est disponible en PDF.

Abstract

Objective

To detect the differentially expressed regulatory miRNAs in the late stage of red blood cell (RBC) preservation and predict their roles.

Methods

Suspended RBCs with different storage periods of 35 day, 42 day, and 50 day were collected for routine blood tests, RNA extraction, and preparation of small RNA sequencing libraries. The constructed libraries were sequenced and the biological functions of differential miRNAs in RBCs in the late storage were analyzed by bioinformatics.

Results

Routine indicators of RBCs in the late stage were not significantly affected by preservation time. The Pearson correlation analysis performing on RBC miRNAs with different storage days revealed that RBC miRNAs changed with the increase of storage days. RBC miRNAs from day 35 (D35), day 42 (D42) and day 50 (D50) showed significant differences (P < 0.05). Compared RBC miRNAs from D42 with these from D35, there were 690 up-regulated miRNAs and 82 down-regulated miRNAs; compared RBC miRNAs from D50 with these from D35, there were 638 up-regulated miRNAs and 123 down-regulated miRNAs; compared RBC miRNAs from D42 with these from D50, there were 271 up-regulated miRNAs and 515 down-regulated miRNAs. GO enrichment analysis of target genes of differential miRNAs were mainly involved in cell metabolism, biosynthesis, protein modification, gene expression and transcriptional regulation of biological processes. KEGG pathway enrichment analysis of miRNA target genes showed that differential miRNA target genes were closely related to pathways in cancer.

Conclusion

MiRNAs were differentially expressed in the late stage of RBC preservation, and may be involved in various biological processes, especially cancer.

Le texte complet de cet article est disponible en PDF.

Keywords : Red blood cell, miRNAs, Differential expression, Late stage, Cancer


Plan


© 2024  Socit francophone de transfusion sanguine (SFTS). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 31 - N° 4

P. 229-236 - novembre 2024 Retour au numéro
Article précédent Article précédent
  • Immune cell kinetics after allogeneic red blood cell transfusion in patients undergoing cardiovascular surgery
  • Marie Yamada, Mami Nakao, Naotomo Yamada, Hideaki Nakamura, Manabu Itoh, Junji Yunoki, Keiji Kamohara, Shinya Kimura, Eisaburo Sueoka
| Article suivant Article suivant
  • Stratified analysis of risk factors affecting vasovagal reactions in first-time whole blood donors: A regional multi-center donor hemovigilance data study
  • Jiangxiu Li, Junhong Yang, Qiuai Yang, Shengji Zhang, Hongbo Liu, Li Zhou, Xia Huang

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.